Head and Neck Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Dr. Bauml on HPV Vaccination for Head and Neck Cancer - OncLive



OncLive
 
Dr. Bauml on HPV Vaccination for Head and Neck Cancer 
OncLive
Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses HPV vaccination for patients with HPV-related head and neck cancer. In HPV-related cancers, there are predictable epitopes that can be targeted ...

and more » 


Head and Neck Cancer Pipeline Report 2017 - ResearchAndMarkets.com - Business Wire (press release)



?ns?d?r C?r N?ws
 
Head and Neck Cancer Pipeline Report 2017 - ResearchAndMarkets.com 
Business Wire (press release)
However, the drug experiences limited off-label use due to its category 2B recommendation from the National Comprehensive Cancer Network, and is under Phase III development for use in emerging markets. Imfinzi is expected to be the third immunotherapy ...
Head and Neck Cancer Marketed Drugs Research Report 2017 - ResearchAndMarkets.com Digital Journal
Head and Neck Cancer Treatment China Market Research & Forecast: Top Key Players as Bristol-Myers Squibb, Eli ... The Financial
Head and Neck Cancer Treatment Report 2017: Treatment, Epidemiology, Marketed Drugs, Pipeline & Forecast ... PharmiWeb.com (press release)
?ns?d?r C?r N?ws 
all 6 news articles » 


Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer - Cancer Network



Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer 
Cancer Network
?Head and neck tumors that are caused by HPV respond well to therapy and can be cured reliably,? said Tanguy Seiwert, MD, of the University of Chicago Medicine, in a press release. ?In fact, the effectiveness of combined treatment with radiation and ...

 


New developments in the management of head and neck cancer ... - Dove Medical Press



New developments in the management of head and neck cancer ... 
Dove Medical Press
New developments in the management of head and neck cancer - impact of pembrolizumab Khalil Saleh, Roland Eid, Fady GH Haddad, Nadine Khalife-Saleh, Hampig Raphaƫl Kourie Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut ...

and more » 


Novel De-escalation Approach for HPV+ Head and Neck Cancer - Medscape



Medscape
 
Novel De-escalation Approach for HPV+ Head and Neck Cancer 
Medscape
A study of a novel approach to de-escalating treatment for HPV-positive head and neck cancer shows excellent pathologic complete response and survival outcomes.
Educational gap exposed on HPV link to head and neck cancer ... medwireNews

all 3 news articles » 


Durvalumab Shows Promise in Advanced Head and Neck Cancer - Cancer Network



Durvalumab Shows Promise in Advanced Head and Neck Cancer 
Cancer Network
Siu presented results of the phase II CONDOR trial at the 2018 Multidisciplinary Head and Neck Cancers Symposium, held February 15?17 in Scottsdale, Arizona. The trial included 267 patients, randomized to receive either durvalumab plus tremelimumab ...

 


Depression Worsens Outcomes in Head and Neck Cancer, But Not ... - Curetoday.com



Depression Worsens Outcomes in Head and Neck Cancer, But Not ... 
Curetoday.com
A recent study showed that patients with head and neck cancer who had greater depressive symptoms had shorter survival, higher rates of chemoradiation interruption and poorer treatment response. However, there are ways to manage these symptoms.
Head and Neck Cancer Treatment Market 2018 to 2025 Market News Access
Head and Neck cancer (HNC) Industry Overview with Total Market ... satPRnews (press release)

all 11 news articles » 


Imfinzi Seen to Safely Help Certain Patients with Advanced Head and Neck Cancer in Phase 2 Trial - Immuno-Oncology News



Immuno-Oncology News
 
Imfinzi Seen to Safely Help Certain Patients with Advanced Head and Neck Cancer in Phase 2 Trial 
Immuno-Oncology News
The CONDOR trial (NCT02319044) enrolled 267 people with advanced head and neck cancers ? those of the oral cavity, oropharynx, hypopharynx or larynx ? who had failed to respond to prior platinum-based chemotherapy. In the majority of patients (64 ...

 


Global Head and Neck Cancer Market 2017-2026: Full Disease ... - Business Wire (press release)



Global Head and Neck Cancer Market 2017-2026: Full Disease ... 
Business Wire (press release)
Head and neck cancer is the sixth most common cancer worldwide, and includes malignancies that can originate in the oral cavity, salivary glands, sinuses, and throat. Around 90% of cases have an epithelial origin, which present as squamous cell ...

and more » 


Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows - Immuno-Oncology News



Immuno-Oncology News
 
Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows 
Immuno-Oncology News
?Thus, we are compelled to evaluate whether adding immunotherapy to the initial treatment of head and neck cancer could prevent these relapses from happening.? The RTOG Foundation 3504 study (NCT02764593) assessed the safety and feasibility of adding ...